Short Interest in Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Expands By 21.8%

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 310,900 shares, an increase of 21.8% from the September 30th total of 255,300 shares. Based on an average trading volume of 400 shares, the short-interest ratio is currently 777.3 days.

Kyowa Kirin Stock Performance

Kyowa Kirin stock remained flat at $16.68 during midday trading on Wednesday. Kyowa Kirin has a 12-month low of $15.78 and a 12-month high of $22.21. The business’s fifty day moving average is $20.21 and its two-hundred day moving average is $18.59.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.